Skip to content
2000
Volume 20, Issue 11
  • ISSN: 1574-888X
  • E-ISSN: 2212-3946

Abstract

Introduction

Pulmonary fibrosis, a condition characterized by excessive lung tissue scarring, remains a significant therapeutic challenge. Given the potential of human Wharton’s jelly-derived mesenchymal stem cells (hWJ-MSCs) and their small extracellular vesicles (hWJ-MSC-EVs) as minimally invasive and scalable therapeutic options for pulmonary fibrosis in clinical settings, this study investigates the potential of hWJ-MSCs and hWJ-MSC-EVs in mitigating bleomycin-induced lung injury in C57BL/6J mice.

Methods

hWJ-MSCs were cultured and characterized for their ability to differentiate into osteogenic, adipogenic, and chondrogenic lineages. EVs were successfully induced serum starvation, purified using ultracentrifugation, and characterized for their protein and nucleic acid content, size distribution, and EV markers. A bleomycin-induced pulmonary fibrosis model was established in C57BL/6J mice. Mice were monitored for weight loss, mortality, and lung fibrosis severity following treatment with hWJ-MSCs and hWJ-MSC-EVs. Histological analysis and Ashcroft scoring were used to assess lung fibrosis.

Results

Bleomycin administration in mice resulted in significant weight loss, increased mortality, and severe lung fibrosis, as demonstrated by histological analysis and Ashcroft scoring. Treatment with hWJ-MSCs and hWJ-MSC-EVs significantly alleviated these symptoms. Mice receiving these treatments exhibited improved body weight, enhanced survival rates, and reduced lung fibrosis, with notable improvements in alveolar structure and decreased fibrotic tissue deposition.

Conclusion

These findings highlight the potential of hWJ-MSCs and hWJ-MSC-EVs as therapeutic agents in treating pulmonary fibrosis by reducing inflammation and promoting lung tissue repair, offering a potential new avenue for regenerative therapy in severe lung diseases. Future research directions involve elucidating the molecular pathways involved in tissue repair, optimizing therapeutic delivery, and conducting comprehensive clinical evaluations.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cscr/10.2174/011574888X366742250417065341
2025-04-25
2025-12-08

  • From This Site

    /content/journals/cscr/10.2174/011574888X366742250417065341
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. HuangW.J. TangX.X. Virus infection induced pulmonary fibrosis.J. Transl. Med.202119149610.1186/s12967‑021‑03159‑934876129
     [Google Scholar]
  2. LongM.E. MallampalliR.K. HorowitzJ.C. Pathogenesis of pneumonia and acute lung injury.Clin. Sci.20221361074776910.1042/CS2021087935621124
     [Google Scholar]
  3. MaherT.M. BendstrupE. DronL. LangleyJ. SmithG. KhalidJ.M. PatelH. KreuterM. Global incidence and prevalence of idiopathic pulmonary fibrosis.Respir. Res.202122119710.1186/s12931‑021‑01791‑z34233665
     [Google Scholar]
  4. AliR.M.M. GhonimyM.B.I. Post-COVID-19 pneumonia lung fibrosis: A worrisome sequelae in surviving patients.Egypt. J. Radiol. Nucl. Med.202152110110.1186/s43055‑021‑00484‑3
     [Google Scholar]
  5. DabrowskaS. AndrzejewskaA. JanowskiM. LukomskaB. Immunomodulatory and regenerative effects of mesenchymal stem cells and extracellular vesicles: Therapeutic outlook for inflammatory and degenerative diseases.Front. Immunol.20211159106510.3389/fimmu.2020.59106533613514
     [Google Scholar]
  6. WuJ. YangZ. WangD. XiaoY. ShaoJ. RenK. Human umbilical cord mesenchymal stem cell-derived exosome regulates intestinal type 2 immunity.Curr. Stem Cell Res. Ther.20241938779734
     [Google Scholar]
  7. DaviesJ.E. WalkerJ.T. KeatingA. Concise review: Wharton’s jelly: The rich, but enigmatic, source of mesenchymal stromal cells.Stem Cells Transl. Med.2017671620163010.1002/sctm.16‑049228488282
     [Google Scholar]
  8. LiX. PengB. ZhuX. WangP. XiongY. LiuH. SunK. WangH. OuL. WuZ. LiuX. HeH. MoS. PengX. TianY. ZhangR. YangL. Changes in related circular RNAs following ERβ knockdown and the relationship to rBMSC osteogenesis.Biochem. Biophys. Res. Commun.2017493110010710.1016/j.bbrc.2017.09.06828919414
     [Google Scholar]
  9. KalluriR. LeBleuV.S. The biology, function, and biomedical applications of exosomes.Science20203676478eaau697710.1126/science.aau697732029601
     [Google Scholar]
  10. LinS.Q. WangK. PanX.H. RuanG.P. Mechanisms of stem cells and their secreted exosomes in the treatment of autoimmune diseases.Curr. Stem Cell Res. Ther.202419111415142810.2174/011574888X27134423112905300338311916
     [Google Scholar]
  11. LiaoW. LiX. TangX. Human umbilical cord mesenchymal stem cells alleviate chronic salpingitis by modulating macrophage-associated inflammatory factors.Curr. Stem Cell Res. Ther.202419111442144810.2174/011574888X26112823110804393138173206
     [Google Scholar]
  12. TianC. LvG. YeL. ZhaoX. ChenM. YeQ. LiQ. ZhaoJ. ZhuX. PanX. Efficacy and mechanism of highly active umbilical cord mesenchymal stem cells in the treatment of osteoporosis in rats.Curr. Stem Cell Res. Ther.20252019110210.2174/011574888X28491124013110090938357953
     [Google Scholar]
  13. ChenH.X. XuH.J. ZhangW. LuoZ.Y. ZhangZ.X. ShiH.H. DongY-C. XueZ-J. BenY. AnS-J. HucMSCs-derived exosomes protect against 6-hydroxydopamine-induced Parkinson’s disease in rats by inhibiting Caspase-3 expression and suppressing apoptosis.Curr. Stem Cell Res. Ther.20241910.2174/011574888X301827240613063513
     [Google Scholar]
  14. ZhangK. ChengK. Stem cell-derived exosome versus stem cell therapy.Nat Rev Bioeng20231960860910.1038/s44222‑023‑00064‑237359776
     [Google Scholar]
  15. HanC. ZhouJ. LiangC. LiuB. PanX. ZhangY. WangY. YanB. XieW. LiuF. YuX.Y. LiY. Human umbilical cord mesenchymal stem cell derived exosomes encapsulated in functional peptide hydrogels promote cardiac repair.Biomater. Sci.2019772920293310.1039/C9BM00101H31090763
     [Google Scholar]
  16. ShenH. YonedaS. Abu-AmerY. GuilakF. GelbermanR.H. Stem cell-derived extracellular vesicles attenuate the early inflammatory response after tendon injury and repair.J. Orthop. Res.202038111712710.1002/jor.2440631286564
     [Google Scholar]
  17. NooshabadiV.T. KhanmohamadiM. ValipourE. MahdipourS. SalatiA. MalekshahiZ.V. ShafeiS. AminiE. FarzamfarS. AiJ. Impact of exosome-loaded chitosan hydrogel in wound repair and layered dermal reconstitution in mice animal model.J. Biomed. Mater. Res. A2020108112138214910.1002/jbm.a.3695932319166
     [Google Scholar]
  18. ZhouY. XuH. XuW. WangB. WuH. TaoY. ZhangB. WangM. MaoF. YanY. GaoS. GuH. ZhuW. QianH. Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro.Stem Cell Res. Ther.2013423410.1186/scrt19423618405
     [Google Scholar]
  19. ZargarM.J. KavianiS. VaseiM. Soufi ZomorrodM. Heidari KeshelS. SoleimaniM. Therapeutic role of mesenchymal stem cell-derived exosomes in respiratory disease.Stem Cell Res. Ther.202213119410.1186/s13287‑022‑02866‑435550188
     [Google Scholar]
  20. FengY. GuoK. JiangJ. LinS. Mesenchymal stem cell-derived exosomes as delivery vehicles for non-coding RNAs in lung diseases.Biomed. Pharmacother.202417011600810.1016/j.biopha.2023.11600838071800
     [Google Scholar]
  21. ZhouX. LiuY. XieJ. WenZ. YangJ. ZhangH. ZhouZ. ZhangJ. CuiH. MaJ. MSC-derived extracellular vesicles against pulmonary fibrosis of rodent model: A meta-analysis.Curr. Stem Cell Res. Ther.2025201728210.2174/1574888X1866623081711155937592780
     [Google Scholar]
  22. B MooreB. LawsonW.E. OuryT.D. SissonT.H. RaghavendranK. HogaboamC.M. B. Moore B Animal models of fibrotic lung disease.Am. J. Respir. Cell Mol. Biol.201349216717910.1165/rcmb.2013‑0094TR23526222
     [Google Scholar]
  23. MoellerA. AskK. WarburtonD. GauldieJ. KolbM. The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?Int. J. Biochem. Cell Biol.200840336238210.1016/j.biocel.2007.08.01117936056
     [Google Scholar]
  24. DominiciM. Le BlancK. MuellerI. Slaper-CortenbachI. MariniF.C. KrauseD.S. DeansR.J. KeatingA. ProckopD.J. HorwitzE.M. Minimal criteria for defining multipotent mesenchymal stromal cells. The International society for cellular Therapy position statement.Cytotherapy20068431531710.1080/1465324060085590516923606
     [Google Scholar]
  25. GeethaG. Mesenchymal stem cell culture in aligned porous hydroxyapatite scaffolds using a multiwell plate bioreactor for bone tissue engineering.MedComm – Future Med202211e17
     [Google Scholar]
  26. ChhoyP. BrownC.W. AmanteJ.J. MercurioA.M. Protocol for the separation of extracellular vesicles by ultracentrifugation from in vitro cell culture models.STAR Protocols20212110030310.1016/j.xpro.2021.10030333554138
     [Google Scholar]
  27. HarasztiR.A. MillerR. DubukeM.L. RockwellH.E. ColesA.H. SappE. DidiotM.C. EcheverriaD. StoppatoM. SereY.Y. LeszykJ. AltermanJ.F. GodinhoB.M.D.C. HasslerM.R. McDanielJ. NarainN.R. WollacottR. WangY. ShafferS.A. KiebishM.A. DiFigliaM. AroninN. KhvorovaA. Serum deprivation of mesenchymal stem cells improves exosome activity and alters lipid and protein composition.iScience20191623024110.1016/j.isci.2019.05.02931195240
     [Google Scholar]
  28. WillmsE. JohanssonH.J. MägerI. LeeY. BlombergK.E.M. SadikM. AlaargA. SmithC.I.E. LehtiöJ. EL AndaloussiS. WoodM.J.A. VaderP. Cells release subpopulations of exosomes with distinct molecular and biological properties.Sci. Rep.2016612251910.1038/srep2251926931825
     [Google Scholar]
  29. ShekariF. AlibhaiF.J. BaharvandH. BörgerV. BrunoS. DaviesO. GiebelB. GimonaM. SalekdehG.H. Martin-JaularL. MathivananS. NelissenI. Nolte-’t HoenE. O’DriscollL. PerutF. PluchinoS. PocsfalviG. SalomonC. SoekmadjiC. StaubachS. TorrecilhasA.C. ShelkeG.V. TertelT. ZhuD. ThéryC. WitwerK. NieuwlandR. Cell culture-derived extracellular vesicles: Considerations for reporting cell culturing parameters.J. Extracell. Biol.2023210e11510.1002/jex2.11538939735
     [Google Scholar]
  30. WelshJ.A. GoberdhanD.C.I. O’DriscollL. BuzasE.I. BlenkironC. BussolatiB. CaiH. Di VizioD. DriedonksT.A.P. ErdbrüggerU. Falcon-PerezJ.M. FuQ.L. HillA.F. LenassiM. LimS.K. MahoneyM.G. MohantyS. MöllerA. NieuwlandR. OchiyaT. SahooS. TorrecilhasA.C. ZhengL. ZijlstraA. AbuelreichS. BagabasR. BergeseP. BridgesE.M. BrucaleM. BurgerD. CarneyR.P. CocucciE. CrescitelliR. HanserE. HarrisA.L. HaugheyN.J. HendrixA. IvanovA.R. Jovanovic-TalismanT. Kruh-GarciaN.A. Ku’ulei-Lyn FaustinoV. KyburzD. LässerC. LennonK.M. LötvallJ. MaddoxA.L. Martens-UzunovaE.S. MizenkoR.R. NewmanL.A. RidolfiA. RohdeE. RojalinT. RowlandA. SafticsA. SandauU.S. SaugstadJ.A. ShekariF. SwiftS. Ter-OvanesyanD. TosarJ.P. UseckaiteZ. ValleF. VargaZ. van der PolE. van HerwijnenM.J.C. WaubenM.H.M. WehmanA.M. WilliamsS. ZendriniA. ZimmermanA.J. ThéryC. WitwerK.W. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches.J. Extracell. Vesicles2024132e1240410.1002/jev2.1240438326288
     [Google Scholar]
  31. KimS.N. LeeJ.S. YangH.S. ChoJ.W. KwonS.J. KimY.B. HerJ.D. ChoK.H. SongC.W. LeeK.H. Dose-response effects of bleomycin on inflammation and pulmonary fibrosis in mice.Toxicol. Res.201026321722210.5487/TR.2010.26.3.21724278527
     [Google Scholar]
  32. GiriJ. GalipeauJ. Mesenchymal stromal cell therapeutic potency is dependent upon viability, route of delivery, and immune match.Blood Adv.2020491987199710.1182/bloodadvances.202000171132384543
     [Google Scholar]
  33. AshcroftT. SimpsonJ.M. TimbrellV. Simple method of estimating severity of pulmonary fibrosis on a numerical scale.J. Clin. Pathol.198841446747010.1136/jcp.41.4.4673366935
     [Google Scholar]
  34. HübnerR.H. GitterW. Eddine El MokhtariN. MathiakM. BothM. BolteH. Freitag-WolfS. BewigB. Standardized quantification of pulmonary fibrosis in histological samples.Biotechniques2008444507517, 514-51710.2144/00011272918476815
     [Google Scholar]
  35. KrishnanA. MuthusamyS. FernandezF.B. KasojuN. Mesenchymal stem cell-derived extracellular vesicles in the management of covid19-associated lung injury: A review on publications, clinical trials and patent landscape.Tissue Eng. Regen. Med.202219465967310.1007/s13770‑022‑00441‑935384633
     [Google Scholar]
  36. ReinerA.T. WitwerK.W. van BalkomB.W.M. de BeerJ. BrodieC. CortelingR.L. GabrielssonS. GimonaM. IbrahimA.G. de KleijnD. LaiC.P. LötvallJ. del PortilloH.A. ReischlI.G. RiazifarM. SalomonC. TaharaH. TohW.S. WaubenM.H.M. YangV.K. YangY. YeoR.W.Y. YinH. GiebelB. RohdeE. LimS.K. Concise review: Developing best-practice models for the therapeutic use of extracellular vesicles.Stem Cells Transl. Med.2017681730173910.1002/sctm.17‑005528714557
     [Google Scholar]
  37. ValadiH. EkströmK. BossiosA. SjöstrandM. LeeJ.J. LötvallJ.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.Nat. Cell Biol.20079665465910.1038/ncb159617486113
     [Google Scholar]
  38. ZhangY. ZhangdiH. NieX. WangL. WanZ. JinH. PuR. LiangM. ChangY. GaoY. ZhangH. JinS. Exosomes derived from BMMSCs mitigate the hepatic fibrosis via anti-pyroptosis pathway in a cirrhosis model.Cells20221124400410.3390/cells1124400436552767
     [Google Scholar]
  39. KowalJ. ArrasG. ColomboM. JouveM. MorathJ.P. Primdal-BengtsonB. DingliF. LoewD. TkachM. ThéryC. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes.Proc. Natl. Acad. Sci. USA20161138E968E97710.1073/pnas.152123011326858453
     [Google Scholar]
  40. ZhangC. LiaoW. LiW. LiM. XuX. SunH. XueY. LiuL. QiuJ. ZhangC. ZhangX. YeJ. DuJ. DengD.Y.B. DengW. LiT. Human umbilical cord mesenchymal stem cells derived extracellular vesicles alleviate salpingitis by promoting M1–to–M2 transformation.Front. Physiol.202314113170110.3389/fphys.2023.113170136875046
     [Google Scholar]
  41. GilhodesJ.C. JuléY. KreuzS. StierstorferB. StillerD. WollinL. Quantification of pulmonary fibrosis in a bleomycin mouse model using automated histological image analysis.PLoS One2017121e017056110.1371/journal.pone.0170561
     [Google Scholar]
  42. DecologneN. WettsteinG. KolbM. MargettsP. GarridoC. CamusP. BonniaudP. Bleomycin induces pleural and subpleural fibrosis in the presence of carbon particles.Eur. Respir. J.201035117618510.1183/09031936.0018180819574324
     [Google Scholar]
  43. TashiroJ. RubioG.A. LimperA.H. WilliamsK. ElliotS.J. NinouI. AidinisV. TzouvelekisA. GlassbergM.K. Exploring animal models that resemble idiopathic pulmonary fibrosis.Front. Med.2017411810.3389/fmed.2017.0011828804709
     [Google Scholar]
  44. MatthayM.A. GoolaertsA. HowardJ.P. Woo LeeJ. Mesenchymal stem cells for acute lung injury: Preclinical evidence.Crit. Care Med.20103810Suppl.S569S57310.1097/CCM.0b013e3181f1ff1d21164399
     [Google Scholar]
  45. RubioG.A. ElliotS.J. WikramanayakeT.C. XiaX. Pereira-SimonS. ThallerS.R. GlinosG.D. JozicI. HirtP. PastarI. Tomic-CanicM. GlassbergM.K. Mesenchymal stromal cells prevent bleomycin-induced lung and skin fibrosis in aged mice and restore wound healing.J. Cell. Physiol.201823385503551210.1002/jcp.2641829271488
     [Google Scholar]
  46. MansouriN. WillisG.R. Fernandez-GonzalezA. ReisM. NassiriS. MitsialisS.A. KourembanasS. Mesenchymal stromal cell exosomes prevent and revert experimental pulmonary fibrosis through modulation of monocyte phenotypes.JCI Insight2019421e12806010.1172/jci.insight.12806031581150
     [Google Scholar]
  47. LiR. XiaoC. LiuH. HuangY. DilgerJ.P. LinJ. Effects of local anesthetics on breast cancer cell viability and migration.BMC Cancer201818166610.1186/s12885‑018‑4576‑229914426
     [Google Scholar]
  48. LiuH. DilgerJ.P. LinJ. Effects of local anesthetics on cancer cells.Pharmacol. Ther.202021210755810.1016/j.pharmthera.2020.10755832343985
     [Google Scholar]
  49. JinZ. ZhangW. LiuH. DingA. LinY. WuS.X. LinJ. Potential therapeutic application of local anesthetics in cancer treatment.Recent Patents Anticancer Drug Discov.202217432634210.2174/157489281766622011912120435043766
     [Google Scholar]
/content/journals/cscr/10.2174/011574888X366742250417065341
Loading
Human Wharton’s Jelly Mesenchymal Stem Cells and their Extracellular Vesicles in the Management of Bleomycin-induced Lung Injury in Model Animals: A Comparative Preclinical Study Focused on Histomorphometric Analysis
Curr Stem Cell Res Ther 20, 1184 (2025); https://doi.org/10.2174/011574888X366742250417065341
/content/journals/cscr/10.2174/011574888X366742250417065341
/content/journals/cscr/10.2174/011574888X366742250417065341
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher's website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): bleomycin-induced lung injury; extracellular vesicles; histomorphometric analysis, pulmonary fibrosis, regenerative medicine, biotherapeutics; Human wharton’s jelly; mesenchymal stem cells

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test